PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NIH grant funds research on work-related asthma among nurses

A researcher at the Zuckerman College of Public Health will use a $750,000 grant to develop methodology to inform cleaning and disinfecting protocols and help educate nurses about asthma risks.

NIH grant funds research on work-related asthma among nurses
2024-03-21
(Press-News.org) A researcher at the University of Arizona Mel and Enid Zuckerman College of Public Health received a $750,000 National Institutes of Health grant to study the asthma risks associated with the use of cleaning and disinfecting products among nurses.

Cleaning processes in health care facilities involve an inherent “risk-risk tradeoff.” Increased use of cleaning and disinfection products leads to increased work-related asthma risks and simultaneously a decrease in occupational-infection risks.

Preliminary survey data indicate that nurses are generally willing to increase infection risks to maintain lower asthma risks if they think they will recover.

“Translating these concerns into cleaning and disinfection protocol changes is challenging due to logistical constraints and the lack of awareness about asthma risks,” said principal investigator Amanda Wilson, PhD, an assistant professor in the Zuckerman College of Public Health’s Department of Community, Environment and Policy.

Wilson will use the five-year National Heart, Lung and Blood Institute grant to gather data that can advance methodologies for relating tolerable occupational respiratory-disease risks to nurses and guide public health policies.

In 2022, there were more than 3 million registered nurses in the United States and more than 56,000 of them worked in Arizona, according to the U.S. Bureau of Labor Statistics. Asthma affects more than 27 million people in the United States, or about 1 in 12 Americans, according to the Asthma and Allergy Foundation of America.

The study, “Work-related Asthma Risk for Nursing Staff Conducting Cleaning and Disinfection: Translation of Risk-risk Tradeoff Methodology,” is funded through a K01 Mentored Research Scientist Career Development Award that provides support for early-career researchers.

“Dr. Amanda Wilson earned her PhD with us here in the Zuckerman College of Public Health, and she is on her way to becoming an outstanding public health researcher,” said Iman Hakim, MD, PhD, MPH, dean of the Zuckerman College of Public Health. “We are so proud of all she has accomplished. This new award shows that she is on her way to making a real difference in public health and respiratory research.”

Wilson’s mentors from the Zuckerman College of Public Health include adjunct professor Lynn Gerald, PhD; professor Paloma Beamer, PhD; and adjunct professor Phil Harber, MD, MPH. Other mentors include Benjamin Wilfond, MD, of the University of Washington, Susan Chilton of Newcastle University and David Resnik, JD, PhD, of the National Institute of Environmental Health Sciences.

This research is supported in part by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health, under award number K01HL168014.

END

[Attachments] See images for this press release:
NIH grant funds research on work-related asthma among nurses NIH grant funds research on work-related asthma among nurses 2

ELSE PRESS RELEASES FROM THIS DATE:

AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients

AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients
2024-03-21
Milan, Italy: A team of international researchers have developed an artificial intelligence (AI) tool that can predict which breast cancer patients may be at risk of side effects after surgery and radiotherapy.   Dr Tim Rattay told the 14th European Breast Cancer Conference (EBCC14) in Milan today (Thursday) that the tool will be tested in a clinical trial that will start recruiting in the last quarter of this year in three countries: France, The Netherlands and the UK.   “It is an explainable AI tool, which means that it shows the reasoning behind its decision-making. This makes it ...

Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

2024-03-20
A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a new study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators. The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only improved invasive-free survival in women with this type of early-stage breast cancer, but also improves distant disease-free survival and recurrence-free survival. The results were published today in the New England ...

Social isolation linked to biological age gap, higher mortality rate

2024-03-20
ROCHESTER, Minn. — A new study from Mayo Clinic finds that socially isolated people are more likely to show signs of being biologically older than their age and more likely to die from a variety of causes. The research, published in the Journal of the American College of Cardiology: Advances, suggests that social connection plays an important role in overall physical health and longevity, and it should be addressed as a necessary part of the social determinants of health. To investigate the role of social contact in biological aging, the ...

New commentary: Combatting digital redlining is imperative for advancing health equity

2024-03-20
Broadband plays a critical role in most aspects of modern-day life, yet over 42 million Americans still lack access to high-speed Internet. This digital divide is driven by “digital redlining”—discriminatory disinvestment in broadband infrastructure that disproportionately affects people of color, low-income communities, and rural populations, worsening disparities in access to healthcare, social services, education, and employment for these populations. Addressing digital redlining and the digital divide is imperative for ...

Drug-pricing program improved prostate cancer treatment adherence

2024-03-20
ANN ARBOR, Michigan — Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation.   The 340B Drug Pricing Program is a federal program that requires the pharmaceutical industry to provide a discount on the cost of drugs to participating hospitals who serve a disproportionate number of Medicare and Medicaid patients. The program was started to enable hospitals to stretch scarce resources, ...

Prenatal exposure to antiseizure medication topiramate may not increase children’s risk of autism spectrum disorder

2024-03-20
Embargoed for release: Wednesday, March 20, 5:00 PM ET Key points: In a study of 4.3 million pregnant women and their children, prenatal exposure to topiramate, an antiseizure medication used to treat epilepsy, bipolar disorder, and migraines, was not associated with additional risk of the children developing autism spectrum disorder (ASD). Consistent with previous research, the study also found that prenatal exposure to valproate and lamotrigine—two other antiseizure medications—were associated with ...

Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial

2024-03-20
An investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH). Currently, there is no treatment for GAN and the disease is usually fatal by 30 years of age. Fourteen children with GAN, ages 6 to 14 years, were treated with gene transfer therapy at the NIH Clinical Center and then followed for about six years to assess safety. Results ...

TIFRH study reports scalable and cost-effective method to assemble a safer and durable lithium metal battery

TIFRH study reports scalable and cost-effective method to assemble a safer and durable lithium metal battery
2024-03-20
Lithium metal batteries (LMBs) can provide nearly 10 times higher energy density compared to the present Lithium-ion batteries (LIBs) and hence are identified as one of the potential future storage systems. However, LMBs pose certain safety concerns and cannot be used for fast-charging applications. Uncontrolled dendrite formation, leading to excessive heating and battery short circuit is one of the critical challenges of its advancement. Researchers have previously attempted to address the safety concerns in LMBs but with methods that were laboursome and money/time intensive. T. N. Narayanan’s lab at the Tata Institute ...

Pediatric cancer research foundation expands executive leadership team

Pediatric cancer research foundation expands executive leadership team
2024-03-20
IRVINE, CA, March 20, 2024 --The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, today announced the expansion of its leadership team. Executive Director Jeri Wilson, who has led the organization for 12 years, will step into the newly created role of Vice President of Development, Principal Gifts.  Danielle Fragalla, a known nonprofit leader in California, will become Chief Executive Officer. In the 12 years Ms. Wilson has led the Foundation, it has grown from a grassroots ...

Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay

Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
2024-03-20
“These results suggest strong potential for clinical use of the assay in ctDNA monitoring of solid tumor cancers.” BUFFALO, NY- March 20, 2024 – A new research paper was published in Oncotarget's Volume 15 on March 14, 2024, entitled, “Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.” In this new study, researchers Josette Northcott, Gabor Bartha, Jason Harris, Conan Li, Fabio C.P. Navarro, Rachel Marty Pyke, Manqing Hong, Qi Zhang, Shuyuan Ma, Tina X. Chen, Janet Lai, Nitin Udar, Juan-Sebastian Saldivar, Erin Ayash, ...

LAST 30 PRESS RELEASES:

Herpes virus plays interior designer with human DNA

Arctic peatlands expanding as climate warms

When Earth iced over, early life may have sheltered in meltwater ponds

Alps could face a doubling in torrential summer rainfall frequency as temperatures rise by 2°C

Fitness trackers for people with obesity miss the mark. This algorithm will fix that.

“The models were right”: Astronomers find ‘missing’ matter

UBC scientists propose blueprint for 'universal translator' in quantum networks

Some of your AI prompts could cause 50 times more CO2 emissions than others

Pandora’s microbes – The battle for iron in the lungs

Unlocking the secrets of gene therapy delivery: New insights into genome ejection from AAV vectors

Scientists use AI to make green ammonia even greener

Remaking psychiatry with biological testing

Caution required when heading soccer balls

Intermittent fasting comparable to traditional diets for weight loss

Community based mentoring in Sierra Leone for pregnant adolescents and their babies doubles survival rates

Positive life outlook may protect against middle-aged memory loss, 16-year study suggests

Scientists find three years left of remaining carbon budget for 1.5°C

Anti-aging drug Rapamycin extends lifespan as effectively as eating less

Babies can sense pain before they can understand it

Consensus statement on universal chemosensory testing calls for better standardization, infrastructure, and education in the field

Two-part vaccine strategy generates a stronger, longer-lasting immune boost against HIV

How lottery-style bottle returns could transform recycling

Researchers with UTHealth Houston School of Public Health awarded $5 million to study cancer risk among firefighters in Texas

C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes

What is a brain age gap, and how may it affect thinking and memory skills?

Food insecurity, neighborhood, lack of social support, linked to worse stroke recovery

Scientists discover new approach to gene therapy

A statement on the Supreme Court decision

Low social support and a tendency to compare yourself to others may be associated with problematic social media use, per study of 403 Italian adolescents

Which therapy works best for knee arthritis?

[Press-News.org] NIH grant funds research on work-related asthma among nurses
A researcher at the Zuckerman College of Public Health will use a $750,000 grant to develop methodology to inform cleaning and disinfecting protocols and help educate nurses about asthma risks.